Elisabeth Chachaty
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Elisabeth Chachaty has a total of 5 co-authors. Here are the top co-authors by number of shared publications:
- Agnès Meybeck
Service de Réanimation et Maladies Infectieuses, Centre Hospitalier de Tourcoing, 135 Rue du Président Coty, 59200 Tourcoing, France
1 shared publication - Anne Boucher
Service Universitaire des maladies Infectieuses et du Voyageur, Centre Hospitalier Gustave Dron, F-59200, Tourcoing, France
1 shared publication - Eric Senneville
Infectious Diseases Department, Gustave Dron Hospital , Tourcoing
1 shared publication - Maxime Pradier
Service Universitaire des Maladies Infectieuses et du voyageur, Centre Hospitalier Dron, 135 avenue du Président Coty, 59200 Tourcoing, France
1 shared publication Olivier Robineau
Service Universitaire des Maladies Infectieuses et du voyageur, Centre Hospitalier Dron, 135 avenue du Président Coty, 59200 Tourcoing, France
1 shared publication
Latest Publications
- Open Access
- 12 December 2018
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 18 (1) , 646
Mycobacterium mucogenicum bacteremia: major role of clinical microbiologists
Mycobacterium mucogenicum is a rare but emerging cause of infections, especially in immunocompromised patients. We describe a new case of M. mucogenicum catheter-related bloodstream infection in a 34-year-old woman with ovarian cancer. M. mucogenicum was at first considered as a contaminant, and susceptibility testing was not performed. Usual susceptibility of M. mucogenicum motivated prescription of clarithromycin and moxifloxacin. Finally, our isolate was confirmed susceptible to both drugs. Clinical outcome was favorable with no relapse of infection after antibiotics discontinuation despite concomitant chemotherapy. Our case illustrates the need for a clinician-microbiologist dialogue in case of suspected M. mucogenicum infection to avoid delaying appropriate management.
- 12 December 2018
- Published by Springer Nature in BMC Infectious Diseases
- Vol. 18 (1) , 646
Open AccessMycobacterium mucogenicum bacteremia: major role of clinical microbiologists
Mycobacterium mucogenicum is a rare but emerging cause of infections, especially in immunocompromised patients. We describe a new case of M. mucogenicum catheter-related bloodstream infection in a 34-year-old woman with ovarian cancer. M. mucogenicum was at first considered as a contaminant, and susceptibility testing was not performed. Usual susceptibility of M. mucogenicum motivated prescription of clarithromycin and moxifloxacin. Finally, our isolate was confirmed susceptible to both drugs. Clinical outcome was favorable with no relapse of infection after antibiotics discontinuation despite concomitant chemotherapy. Our case illustrates the need for a clinician-microbiologist dialogue in case of suspected M. mucogenicum infection to avoid delaying appropriate management.